TCL Archive Only 20 Percent Of At-Risk Patients Are Screened For HBV Before Therapy November 25, 2011
TCL Archive In Brief: Thomas Jordan Promoted At Bristol-Myers, Markison To Succeed Him In Oncology Div. February 28, 1992
TCL Archive Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase December 31, 2010
TCL Archive Three Win Nobel Prize In Medicine; Irving Center Awarded $10M For Breast Cancer Research. October 13, 2000